Fate Therapeutics IncNASDAQ:FATE
- LAST PRICE5.9200
- TODAY'S CHANGE (%)0.6200 (11.6981%)
- Bid / Lots5.8200/ 6
- Ask / Lots5.9200/ 2
- Open / Previous Close5.2900 / 5.3000
- Day Range
- 52 Week Range
- Volume2,770,797
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | FATE |
|---|---|---|
| 09:32 ET | 34993 | 5.3801 |
| 09:33 ET | 16444 | 5.4027 |
| 09:35 ET | 16008 | 5.41 |
| 09:37 ET | 3165 | 5.41 |
| 09:39 ET | 6005 | 5.485 |
| 09:42 ET | 5875 | 5.47 |
| 09:44 ET | 16345 | 5.48 |
| 09:46 ET | 57646 | 5.48 |
| 09:48 ET | 17884 | 5.51 |
| 09:50 ET | 5810 | 5.53 |
| 09:51 ET | 8949 | 5.5866 |
| 09:53 ET | 21593 | 5.515 |
| 09:55 ET | 17447 | 5.55 |
| 09:57 ET | 8452 | 5.55 |
| 10:00 ET | 9641 | 5.55 |
| 10:02 ET | 7866 | 5.565 |
| 10:04 ET | 9734 | 5.607 |
| 10:06 ET | 4130 | 5.5915 |
| 10:08 ET | 13494 | 5.64 |
| 10:09 ET | 10768 | 5.625 |
| 10:11 ET | 10414 | 5.625 |
| 10:13 ET | 20128 | 5.645 |
| 10:15 ET | 3159 | 5.63 |
| 10:18 ET | 3725 | 5.6408 |
| 10:20 ET | 4700 | 5.63 |
| 10:22 ET | 10422 | 5.62 |
| 10:24 ET | 9388 | 5.6206 |
| 10:26 ET | 5200 | 5.6 |
| 10:27 ET | 5500 | 5.57 |
| 10:29 ET | 14888 | 5.6 |
| 10:31 ET | 5383 | 5.6199 |
| 10:33 ET | 7542 | 5.62 |
| 10:36 ET | 18442 | 5.65 |
| 10:38 ET | 11563 | 5.67 |
| 10:40 ET | 33864 | 5.7 |
| 10:42 ET | 6260 | 5.69 |
| 10:44 ET | 5226 | 5.695 |
| 10:45 ET | 4398 | 5.642 |
| 10:47 ET | 5320 | 5.61 |
| 10:49 ET | 7663 | 5.615 |
| 10:51 ET | 5332 | 5.615 |
| 10:54 ET | 9194 | 5.61 |
| 10:56 ET | 8218 | 5.655 |
| 10:58 ET | 9499 | 5.65 |
| 11:00 ET | 2998 | 5.64 |
| 11:02 ET | 2500 | 5.68 |
| 11:03 ET | 2833 | 5.685 |
| 11:05 ET | 7060 | 5.67 |
| 11:07 ET | 1983 | 5.65 |
| 11:09 ET | 11015 | 5.625 |
| 11:12 ET | 12304 | 5.58 |
| 11:14 ET | 5700 | 5.59 |
| 11:16 ET | 5578 | 5.6 |
| 11:18 ET | 3503 | 5.6085 |
| 11:20 ET | 3635 | 5.61 |
| 11:21 ET | 12351 | 5.62 |
| 11:23 ET | 2450 | 5.63 |
| 11:25 ET | 5875 | 5.63 |
| 11:27 ET | 2800 | 5.635 |
| 11:30 ET | 1400 | 5.65 |
| 11:32 ET | 5674 | 5.685 |
| 11:34 ET | 12281 | 5.67 |
| 11:36 ET | 12470 | 5.6899 |
| 11:38 ET | 14128 | 5.665 |
| 11:39 ET | 6410 | 5.635 |
| 11:41 ET | 3216 | 5.63 |
| 11:43 ET | 7630 | 5.665 |
| 11:45 ET | 400 | 5.67 |
| 11:48 ET | 8599 | 5.6911 |
| 11:50 ET | 7072 | 5.69 |
| 11:52 ET | 8128 | 5.7 |
| 11:54 ET | 11003 | 5.715 |
| 11:56 ET | 10851 | 5.71 |
| 11:57 ET | 7231 | 5.72 |
| 11:59 ET | 15292 | 5.73 |
| 12:01 ET | 12393 | 5.75 |
| 12:03 ET | 1421 | 5.7514 |
| 12:06 ET | 8437 | 5.73 |
| 12:08 ET | 8772 | 5.755 |
| 12:10 ET | 6302 | 5.755 |
| 12:12 ET | 18379 | 5.72 |
| 12:14 ET | 3116 | 5.75 |
| 12:15 ET | 3119 | 5.765 |
| 12:17 ET | 7312 | 5.765 |
| 12:19 ET | 2460 | 5.775 |
| 12:21 ET | 9614 | 5.7689 |
| 12:24 ET | 8214 | 5.76 |
| 12:26 ET | 4672 | 5.755 |
| 12:28 ET | 2258 | 5.73 |
| 12:30 ET | 2920 | 5.76 |
| 12:32 ET | 12073 | 5.785 |
| 12:33 ET | 10830 | 5.78 |
| 12:35 ET | 3958 | 5.775 |
| 12:37 ET | 3295 | 5.775 |
| 12:39 ET | 4909 | 5.765 |
| 12:42 ET | 5662 | 5.76 |
| 12:44 ET | 4613 | 5.765 |
| 12:46 ET | 4167 | 5.76 |
| 12:48 ET | 7127 | 5.755 |
| 12:50 ET | 6157 | 5.745 |
| 12:51 ET | 3351 | 5.7453 |
| 12:53 ET | 5261 | 5.7354 |
| 12:55 ET | 12233 | 5.755 |
| 12:57 ET | 12001 | 5.73 |
| 01:00 ET | 2377 | 5.73 |
| 01:02 ET | 5004 | 5.725 |
| 01:04 ET | 13893 | 5.75 |
| 01:06 ET | 680 | 5.7499 |
| 01:08 ET | 800 | 5.745 |
| 01:09 ET | 4658 | 5.735 |
| 01:11 ET | 6072 | 5.73 |
| 01:13 ET | 13008 | 5.75 |
| 01:15 ET | 10741 | 5.75 |
| 01:18 ET | 10927 | 5.75 |
| 01:20 ET | 2471 | 5.745 |
| 01:22 ET | 3358 | 5.75 |
| 01:24 ET | 4647 | 5.75 |
| 01:26 ET | 4554 | 5.7418 |
| 01:27 ET | 5085 | 5.75 |
| 01:29 ET | 5887 | 5.755 |
| 01:31 ET | 3394 | 5.755 |
| 01:33 ET | 6160 | 5.75 |
| 01:36 ET | 1450 | 5.745 |
| 01:38 ET | 1900 | 5.745 |
| 01:40 ET | 6211 | 5.74 |
| 01:42 ET | 14596 | 5.7315 |
| 01:44 ET | 100 | 5.74 |
| 01:45 ET | 5649 | 5.73 |
| 01:47 ET | 16492 | 5.74 |
| 01:49 ET | 4944 | 5.745 |
| 01:51 ET | 5613 | 5.72 |
| 01:54 ET | 5152 | 5.72 |
| 01:56 ET | 10655 | 5.74 |
| 01:58 ET | 3919 | 5.7442 |
| 02:00 ET | 12666 | 5.74 |
| 02:02 ET | 10529 | 5.74 |
| 02:03 ET | 2951 | 5.735 |
| 02:05 ET | 2769 | 5.735 |
| 02:07 ET | 3569 | 5.735 |
| 02:09 ET | 1982 | 5.735 |
| 02:12 ET | 13343 | 5.705 |
| 02:14 ET | 3635 | 5.7 |
| 02:16 ET | 5907 | 5.7192 |
| 02:18 ET | 5601 | 5.72 |
| 02:20 ET | 2104 | 5.73 |
| 02:21 ET | 6290 | 5.7407 |
| 02:23 ET | 11517 | 5.7407 |
| 02:25 ET | 1245 | 5.745 |
| 02:27 ET | 3800 | 5.74 |
| 02:30 ET | 20069 | 5.74 |
| 02:32 ET | 17176 | 5.74 |
| 02:34 ET | 10568 | 5.745 |
| 02:36 ET | 2000 | 5.75 |
| 02:38 ET | 5602 | 5.72 |
| 02:39 ET | 7725 | 5.72 |
| 02:41 ET | 5618 | 5.715 |
| 02:43 ET | 4394 | 5.72 |
| 02:45 ET | 28520 | 5.745 |
| 02:48 ET | 35473 | 5.78 |
| 02:50 ET | 14506 | 5.795 |
| 02:52 ET | 12505 | 5.81 |
| 02:54 ET | 38100 | 5.81 |
| 02:56 ET | 25507 | 5.8261 |
| 02:57 ET | 10049 | 5.835 |
| 02:59 ET | 3763 | 5.835 |
| 03:01 ET | 1350 | 5.832 |
| 03:03 ET | 9147 | 5.84 |
| 03:06 ET | 17803 | 5.8442 |
| 03:08 ET | 15318 | 5.88 |
| 03:10 ET | 5396 | 5.88 |
| 03:12 ET | 10831 | 5.87 |
| 03:14 ET | 18125 | 5.855 |
| 03:15 ET | 14310 | 5.835 |
| 03:17 ET | 9943 | 5.825 |
| 03:19 ET | 44061 | 5.86 |
| 03:21 ET | 18697 | 5.885 |
| 03:24 ET | 11480 | 5.905 |
| 03:26 ET | 14237 | 5.885 |
| 03:28 ET | 11872 | 5.875 |
| 03:30 ET | 8363 | 5.885 |
| 03:32 ET | 11800 | 5.885 |
| 03:33 ET | 58119 | 5.94 |
| 03:35 ET | 8420 | 5.93 |
| 03:37 ET | 21470 | 5.935 |
| 03:39 ET | 9150 | 5.915 |
| 03:42 ET | 14812 | 5.94 |
| 03:44 ET | 19828 | 5.95 |
| 03:46 ET | 25710 | 5.9699 |
| 03:48 ET | 11103 | 5.99 |
| 03:50 ET | 38488 | 5.955 |
| 03:51 ET | 37393 | 6.005 |
| 03:53 ET | 42589 | 6 |
| 03:55 ET | 76184 | 5.96 |
| 03:57 ET | 33685 | 5.9585 |
| 04:00 ET | 402092 | 5.92 |
Today
Jan 27, 2023
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fate Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - FATE, from 7:46PM ET on Friday Jan 27, 2023 by PR Newswire
7:46PM ET on Friday Jan 27, 2023 by PR NewswireFate Therapeutics, Inc. (FATE) Shareholder Notice: Robbins LLP Reminds Investors of Class Action Against Fate Therapeutics, Inc., from 5:23PM ET on Friday Jan 27, 2023 by GlobeNewswire
5:23PM ET on Friday Jan 27, 2023 by GlobeNewswireROSEN, A LEADING LAW FIRM, Encourages Fate Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FATE, from 3:47PM ET on Friday Jan 27, 2023 by Newsfile
3:47PM ET on Friday Jan 27, 2023 by NewsfileDEADLINE ALERT for YMAB, FATE, and SHC: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders, from 2:33PM ET on Friday Jan 27, 2023 by GlobeNewswire
2:33PM ET on Friday Jan 27, 2023 by GlobeNewswire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Fate Therapeutics Inc | 575.2M | -1.9x | --- |
Tango Therapeutics Inc | 575.8M | -5.7x | --- |
2Seventy Bio Inc | 502.4M | -1.4x | --- |
Nurix Therapeutics Inc | 583.7M | -3.3x | --- |
Sorrento Therapeutics Inc | 476.6M | -0.8x | --- |
Merus NV | 683.0M | -10.2x | --- |
Company Information
Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of programmed cellular immunotherapies for patients with cancer. It uses human induced pluripotent stem cells (iPSCs) generated from its proprietary iPSC product platform to create genetically engineered, clonal master iPSC lines having preferred biological properties. The Company is advancing a pipeline of programmed cellular immunotherapies, including off-the-shelf natural killer (NK) and T-cell product candidates derived from clonal master iPSC lines for the treatment of cancer. The Company's product pipeline includes FT596, FT538, FT576, FT536, FT573, FT819, FT500 and FT516. FT516 is an investigational off-the-shelf NK cell cancer immunotherapy derived from a clonal master iPSC line engineered to express a novel CD16 (hnCD16) Fc receptor. FT596 is an investigational off-the-shelf CAR NK cell cancer immunotherapy derived from a clonal engineered master iPSC line.
Contact Information
- Headquarters
- 12278 Scripps Summit DriveSAN DIEGO, CA, United States 92131
- Phone
- 858-875-1803
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- William Rastetter
- President, Chief Executive Officer, Director
- John Wolchko
- Independent Vice Chairman of the Board
- John Mendlein
- Chief Financial Officer
- Edward Dulac
- Chief Technical Officer
- Mark Plavsic
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $575.2M |
|---|---|
Revenue (TTM) | $69.0M |
Shares Outstanding | 97.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.47 |
EPS | $-3.05 |
Book Value | $7.09 |
P/E Ratio | -1.9x |
Price/Sales (TTM) | 8.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -454.04% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
